Quetiapine Fumarate
Product Images NDC 68071-1892

4 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 68071-1892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 1892 3 A141)

Pdp (68071 1892 3 A141)
Label for Quetiapine Fumarate 25 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a package quantity of 30 tablets, each containing 25 mg of Quetiapine Fumarate USP equivalent. The tablets are described as round, peach-colored, and debossed with "262". The label includes NDC 68071-1892-3, a lot number, and storage instructions to keep out of reach of children and store at controlled temperature (59-86°F). The product is labeled Rx Only.*
FDA Label Image

Figure 1 (Quetiapine Fig1)

Figure 1 (Quetiapine Fig1)
Kaplan-Meier curves depicting the proportion of patients with relapse over time (weeks) from a study on mood event recurrence. The graph compares two groups: QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line), showing relapse proportions on the y-axis and time in weeks on the x-axis.*
FDA Label Image

Figure 2 (Quetiapine Fig2)

Figure 2 (Quetiapine Fig2)
Kaplan-Meier curves showing time to recurrence of a mood event from Study 8. The graph plots the proportion of patients with relapse (%) on the y-axis against time in weeks on the x-axis, comparing QTP+ LI/VAL (dashed line) and PLA+ LI/VAL (solid line) treatment groups.*
FDA Label Image

Structure (Quetiapine Stru)

Structure (Quetiapine Stru)
Chemical structure of Quetiapine Fumarate, showing the molecular arrangement of the Quetiapine moiety along with the fumarate component in a 2:1 ratio.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.